Gorecka, MiroslawaMcCann, Gerry PBerry, ColinFerreira, Vanessa MMoon, James CMiller, Christopher AChiribiri, AmedeoPrasad, SanjayDweck, Marc RBucciarelli-Ducci, ChiaraDawson, DanaFontana, MariannaMacfarlane, Peter WMcConnachie, AlexNeubauer, StefanGreenwood, John PCOVID-HEART investigators2021-06-182021-06-182021-06-10Gorecka, M, McCann, G P, Berry, C, Ferreira, V M, Moon, J C, Miller, C A, Chiribiri, A, Prasad, S, Dweck, M R, Bucciarelli-Ducci, C, Dawson, D, Fontana, M, Macfarlane, P W, McConnachie, A, Neubauer, S, Greenwood, J P & COVID-HEART investigators 2021, 'Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19 : protocol design of COVID-HEART-a UK, multicentre, observational study', Journal of Cardiovascular Magnetic Resonance, vol. 23, no. 1, 77. https://doi.org/10.1186/s12968-021-00752-11097-6647PubMedCentral: PMC8190746ORCID: /0000-0003-2815-4469/work/160846667https://hdl.handle.net/2164/16699Acknowledgements CB acknowledges British Heart Foundation support (RE/18/6134217). GPM is funded by a NIHR Research Professorship (RP‐2017‐08‐ST2‐007). CM is funded by a NIHR Clinician Scientist Award (CS‐2015‐15‐003). VMF and SN acknowledge the NIHR Oxford BRC for support of this study. CBD is in part supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. Additional support was provided by the NIHR Leicester Biomedical Research Centre and the NIHR Leeds Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. We thank the patients and staff who have supported this project. Dr. Warren J. Manning served as a Guest Editor for this manuscript. Study Management and Recruitment centres: Grant applicants: JP Greenwood (chief investiga‐ tor), GP McCann, C Berry, M Dweck, J Moon, CM Miller, A Chiribiri, S Prasad, VM Ferreira, C Bucciarelli‐Ducci, D Dawson. Data repository and statistical analysis: Glasgow Clinical Trials Unit. Senior study statistician: Prof A McConnachie, GCTU. Local Principle Investigators and Recruitment Centres: Prof John Green‐ wood, Leeds Teaching Hospitals NHS Trust, UK; Prof Gerry McCann, Glenfield Hospital, Leicester, UK; Prof Dana Dawson, Aberdeen Royal Infirmary, UK; Prof Marc Dweck, Royal Infirmary of Edinburgh, UK; Prof Vanessa Ferreira, JohnRadcliffe Hospital, Oxford, UK; Prof Colin Berry, Queen Elizabeth University Hospital, Glasgow, UK; Dr Peter Swoboda, Pinderfields Hospital, Wakefield, UK; Dr Richard Steeds, Queen Elizabeth Hospital, Birmingham, UK; Prof James Moon, UCL Hospital London, UK; Dr Christopher Miller, Wythenshawe Hospital, Manchester, UK; Dr Timothy Fairbairn, Liverpool Heart and Chest Hospital, UK; Dr Andrew Flett, Southampton General Hospital, UK; Prof Marianna Fontana, Royal Free Hospital, London, UK; Dr Thomas Green, Northumbria NHS Trust, UK; Prof Amedeo Chiribiri, St Thomas’ Hospital, London, UK; Dr Chiara Bucciarelli‐Ducci, University Hospitals Bristol and Weston NHS Trust, UK; Dr Graham Cole, Hammersmith Hospital, London, UK; Prof Sanjay Prasad, Royal Brompton Hospital, London, UK; Dr Adam McDiarmid, Freeman Hospital, New‐ castle Upon Tyne, UK; Dr Nicholas Bunce, St Georges Hospital, London, UK; Dr Prathap Kanagala, Aintree University Hospital, Liverpool, UK; Prof Nicholas Bellenger, The Royal Devon and Exeter Hospital, UK; Dr Tishi Ninan, Swansea Bay University Hospital, UK; Dr Khaled Alfakih, Lewisham University Hospital, London, UK; Prof James Moon, St Bartholomew’s Hospital, London, UK. Funding COVID‐HEART is funded by the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) COVID‐19 Rapid Response Rolling Call (Grant Number COV0254), and sponsored by the University of Leeds, UK. The study has been endorsed by the British Society of Cardiovascular Magnetic Resonance (BSCMR) Research Group, and nationally prioritised, and received both BHF‐NIHR Cardiovascular Partnership Flagship Status, and the NIHR Urgent Public Health Group identified it as an Urgent Public Health (UPH) study. Funding for the translation of the patient information leaflets into non‐ English languages was provided by the West Yorkshire and Humber Clinical Research Network (CV070).131640467engSDG 3 - Good Health and Well-beingCOVID‐19CoronavirusCardiovascular magnetic resonanceMyocarditisMyopericarditisMyocardial infarctionmyocardial injuryMyocardial inflammationMyocardial repairCardiovascular diseaseR MedicineNational Institute for Health Research (NIHR)RP‐2017‐08‐ST2‐007CS‐2015‐15‐003British Heart FoundationRE/18/6134217RJournal article10.1186/s12968-021-00752-1231